ArticleImmunoHorizons2025
Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant.
Sasha E Larsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleImmunoHorizons2025
Sasha E Larsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.